Published in Cell Signal on October 11, 2010
Modeling of tumor progression in NSCLC and intrinsic resistance to TKI in loss of PTEN expression. PLoS One (2012) 0.93
EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma. BMC Cell Biol (2013) 0.89
Signaling cross talk between growth hormone (GH) and insulin-like growth factor-I (IGF-I) in pancreatic islet β-cells. Mol Endocrinol (2011) 0.83
Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions. Int J Endocrinol (2014) 0.79
Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling. Endocrinology (2013) 0.79
Genome scale modeling in systems biology: algorithms and resources. Curr Genomics (2014) 0.75
Cell signaling by receptor tyrosine kinases. Cell (2010) 12.39
Role of platelet-derived growth factors in physiology and medicine. Genes Dev (2008) 8.89
Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A (1990) 7.39
EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature (2000) 7.03
Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A (1997) 4.11
Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature (1987) 3.75
Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell (1993) 3.54
The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol (2008) 2.98
The role of prolactin in mammary carcinoma. Endocr Rev (2003) 2.95
ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol (2006) 2.39
Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol (2006) 2.37
Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone. Nature (1997) 2.20
Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol (1985) 1.99
Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Biol (2003) 1.98
Prolactin: the new biology of an old hormone. Annu Rev Physiol (2002) 1.82
Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol (2001) 1.66
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol (1989) 1.48
Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem (2002) 1.42
Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J Biol Chem (1998) 1.42
Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways. Mol Endocrinol (2003) 1.39
Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem (2000) 1.38
Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor. J Biol Chem (1995) 1.38
Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. J Biol Chem (2003) 1.38
Molecular mechanism of growth hormone action. Annu Rev Physiol (1996) 1.33
ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling. Cell Signal (2008) 1.27
Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer (1998) 1.25
The epidermal growth factor. Cell Biol Int (1995) 1.25
Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells. J Biol Chem (2002) 1.19
Prolactin involvement in breast cancer. Endocr Relat Cancer (1999) 1.19
Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J Biol Chem (1998) 1.10
S1P3-mediated Akt activation and cross-talk with platelet-derived growth factor receptor (PDGFR). FASEB J (2003) 1.08
Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements. Mol Endocrinol (2004) 1.04
Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene (2006) 1.03
The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis (2002) 1.02
Prolactin receptor signal transduction. Lupus (2001) 1.01
Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. J Biol Chem (2003) 1.00
Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins. J Biol Chem (1992) 1.00
Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J Biol Chem (1995) 0.99
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol (2010) 0.99
An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway. Nat Cell Biol (2008) 0.97
Prolactin does not require insulin-like growth factor intermediates but synergizes with insulin-like growth factor I in human breast cancer cells. Mol Cancer Res (2008) 0.95
Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene (1996) 0.94
Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat (1996) 0.94
Advanced rat mammary cancers are growth hormone dependent. Endocrinology (2007) 0.92
Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation. Endocrinology (2000) 0.91
Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells. Endocrinology (2004) 0.90
Should prolactin be reconsidered as a therapeutic target in human breast cancer? Mol Cell Endocrinol (1999) 0.89
Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation. Endocrinology (1997) 0.88
Phospholipase Cgamma1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B. Nat Cell Biol (2006) 0.87
Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells. J Biol Chem (2010) 0.86
Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1. Mol Endocrinol (2009) 0.84
Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts. J Biol Chem (1999) 0.84
Prolactin, epidermal growth factor or transforming growth factor-alpha activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat. Mol Cell Endocrinol (1997) 0.83
A role for Grb2-associated binder-1 in growth hormone signaling. Endocrinology (2002) 0.82
In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R. Int J Oncol (2002) 0.81
Stimulation of growth of human breast cancer cells (T47D) by platelet derived growth factor. Cancer Lett (1991) 0.78
Growth hormone attenuation of epidermal growth factor-induced mitogenesis. J Cell Physiol (1997) 0.78
The impacts of climate change on water resources and agriculture in China. Nature (2010) 7.35
The carbon balance of terrestrial ecosystems in China. Nature (2009) 6.84
Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasome. Cancer Res (2007) 3.85
Prediction of drug-target interactions and drug repositioning via network-based inference. PLoS Comput Biol (2012) 2.63
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis. Nat Med (2009) 2.62
Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med (2004) 2.61
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med (2010) 2.44
Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol (2011) 2.43
Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States. J Clin Oncol (2014) 2.42
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys (2012) 2.17
Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells. Arthritis Rheum (2012) 2.03
E-cadherin-mediated cell-cell contact is critical for induced pluripotent stem cell generation. Stem Cells (2010) 1.97
Complications After Mastectomy and Immediate Breast Reconstruction for Breast Cancer: A Claims-Based Analysis. Ann Surg (2016) 1.86
A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway. Blood (2011) 1.84
Automatically generating gene summaries from biomedical literature. Pac Symp Biocomput (2006) 1.83
miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev (2010) 1.80
FastCloning: a highly simplified, purification-free, sequence- and ligation-independent PCR cloning method. BMC Biotechnol (2011) 1.72
Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int (2011) 1.70
Noninvasive bioluminescence imaging in small animals. ILAR J (2008) 1.59
Transcriptome sequencing and de novo analysis for Ma bamboo (Dendrocalamus latiflorus Munro) using the Illumina platform. PLoS One (2012) 1.51
Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047). J Med Chem (2009) 1.50
Complex threshold method for identifying pixels that contain predominantly noise in magnetic resonance images. J Magn Reson Imaging (2008) 1.47
Removing background phase variations in susceptibility-weighted imaging using a fast, forward-field calculation. J Magn Reson Imaging (2009) 1.39
Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer (2008) 1.38
Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep (2011) 1.38
Modulation of T cell cytokine production by miR-144* with elevated expression in patients with pulmonary tuberculosis. Mol Immunol (2011) 1.35
Pharmacokinetics, pharmacodynamics, metabolism, distribution, and excretion of carfilzomib in rats. Drug Metab Dispos (2011) 1.35
A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. J Neurosci (2009) 1.33
Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of jak2 tyrosine kinase autophosphorylation [correction of autophophorylation]. J Med Chem (2005) 1.32
Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Invest (2010) 1.30
Structure and mechanism of the uracil transporter UraA. Nature (2011) 1.29
ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling. Cell Signal (2008) 1.27
Mode of growth hormone action in osteoblasts. J Biol Chem (2007) 1.27
IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One (2012) 1.25
Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis. Cancer Res (2008) 1.21
Start codon targeted polymorphism for evaluation of functional genetic variation and relationships in cultivated peanut (Arachis hypogaea L.) genotypes. Mol Biol Rep (2010) 1.19
Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology (2008) 1.17
Climate warming over the past three decades has shortened rice growth duration in China and cultivar shifts have further accelerated the process for late rice. Glob Chang Biol (2012) 1.13
Molecular mechanism of photoactivation and structural location of the cyanobacterial orange carotenoid protein. Biochemistry (2013) 1.13
DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target. Cancer Res (2010) 1.12
Stk40 links the pluripotency factor Oct4 to the Erk/MAPK pathway and controls extraembryonic endoderm differentiation. Proc Natl Acad Sci U S A (2010) 1.12
The Asian nitrogen cycle case study. Ambio (2002) 1.12
An inventory of N(2)O emissions from agriculture in China using precipitation-rectified emission factor and background emission. Chemosphere (2006) 1.11
The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol Endocrinol (2013) 1.11
New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values. Magn Reson Med (2007) 1.10
Quantification of soil organic carbon sequestration potential in cropland: a model approach. Sci China Life Sci (2010) 1.09
Modeling soil organic carbon change across Australian wheat growing areas, 1960-2010. PLoS One (2013) 1.09
Correction of the disease phenotype of myocilin-causing glaucoma by a natural osmolyte. Invest Ophthalmol Vis Sci (2009) 1.08
Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: predictors of use and association with toxicities. Lung Cancer (2013) 1.07
China's crop productivity and soil carbon storage as influenced by multifactor global change. Glob Chang Biol (2012) 1.06
Janus kinase 2 determinants for growth hormone receptor association, surface assembly, and signaling. Mol Endocrinol (2003) 1.05
More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells. Cell Res (2009) 1.04
Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements. Mol Endocrinol (2004) 1.04
CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin Cancer Res (2009) 1.04
Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site. J Biol Chem (2002) 1.03
Estimates of synthetic fertilizer N-induced direct nitrous oxide emission from Chinese croplands during 1980-2000. Environ Pollut (2009) 1.03
Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure. Int J Cardiol (2009) 1.01
Germline-competent mouse-induced pluripotent stem cell lines generated on human fibroblasts without exogenous leukemia inhibitory factor. PLoS One (2009) 1.01
Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling. J Biol Chem (2003) 1.00
Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis. Respir Med (2009) 1.00
Genetic polymorphisms of glutathione S-transferase genes and susceptibility to colorectal cancer: a case-control study in an Indian population. Cancer Epidemiol (2010) 1.00
Determinants of growth hormone receptor down-regulation. Mol Endocrinol (2007) 1.00
Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3. Am J Physiol Gastrointest Liver Physiol (2003) 1.00
Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. Mol Endocrinol (2008) 0.99
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling. Mol Endocrinol (2010) 0.99
Impacts of climate change and inter-annual variability on cereal crops in China from 1980 to 2008. J Sci Food Agric (2011) 0.98
Insulin enhances growth hormone induction of the MEK/ERK signaling pathway. J Biol Chem (2005) 0.98
A fast workflow for identification and quantification of proteomes. Mol Cell Proteomics (2013) 0.98
Prolactin stimulates ubiquitination, initial internalization, and degradation of its receptor via catalytic activation of Janus kinase 2. J Endocrinol (2008) 0.98
Janus kinase 2 enhances the stability of the mature growth hormone receptor. Endocrinology (2005) 0.98
Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation. Mol Endocrinol (2007) 0.98
Synthetic fertilizer management for China's cereal crops has reduced N2O emissions since the early 2000s. Environ Pollut (2011) 0.96
Partial redirection of transgenic human growth hormone secretion from rat salivary glands. Hum Gene Ther (2005) 0.96
Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. Mol Endocrinol (2011) 0.96
Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage. J Biol Chem (2005) 0.95
Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells. PLoS One (2011) 0.95
Different developmental potential of pluripotent stem cells generated by different reprogramming strategies. J Mol Cell Biol (2011) 0.95
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis. EMBO Mol Med (2014) 0.95
High-efficiency somatic reprogramming induced by intact MII oocytes. Cell Res (2010) 0.95
Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys (2013) 0.95
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes. Circulation (2002) 0.94
Expression profiling of salinity-alkali stress responses by large-scale expressed sequence tag analysis in Tamarix hispid. Plant Mol Biol (2007) 0.94
Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery. Cancer (2012) 0.94
Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology (2007) 0.94
Caveolar and lipid raft localization of the growth hormone receptor and its signaling elements: impact on growth hormone signaling. J Biol Chem (2004) 0.94